Axa
PRNB

Axa’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Axa’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-106,829
Closed -$6.39M – 1388
2020
Q2 		$6.39M Buy
106,829
+5,295
+5% +$327K 0.03% 544
2020
Q1 		$6.03M Sell
101,534
-61,286
-38% -$3.57M 0.03% 472
2019
Q4 		$8.92M Buy
162,820
+9,760
+6% +$364K 0.04% 476
2019
Q3 		$4.32M Sell
153,060
-270
-0.2% -$9.9K 0.02% 695
2019
Q2 		$5.09M Buy
153,330
+3,330
+2% +$104K 0.02% 651
2019
Q1 		$5.1M Hold
150,000
– – 0.02% 639
2018
Q4 		$4.11M Hold
150,000
– – 0.02% 658
2018
Q3 		$4.38M Buy
+150,000
New +$4.23M 0.02% 711

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Axa's PRNB Position: Q3 2020 in Review

Axa sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 106,829 shares — an estimated $6.39M sold.

Axa first reported a position in PRNB in Q3 2018 and held it in 8 quarters. The position peaked at $8.92M in Q4 2019. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Axa reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Axa sold 106,829 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $6.39M.
  • Axa first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 8 quarters.
  • Axa's Principia Biopharma Inc. Common Stock position peaked at $8.92M in Q4 2019.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Axa's 13F filing for Q3 2020, filed 13 Nov 2020.